LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Mohamed, Dina Mahmoud"
  2. AU="Asante-Addo, Collins"
  3. AU="Belluti, Federica"
  4. AU="Sebastian Fetscher"
  5. AU="Reshef, Yakir A"
  6. AU="Gerstenberger, John"
  7. AU="Bilbul, Melanie" AU="Bilbul, Melanie"
  8. AU="Martínez-Vernaza, Samuel"
  9. AU="Takenoya, Takashi"
  10. AU="Russell, Roslin"
  11. AU=Kim Ka Young
  12. AU="Mateja, Allyson"
  13. AU="Todorov, Alexander B."
  14. AU=Mosallanezhad Behzad
  15. AU=Rochman Yrina AU=Rochman Yrina
  16. AU="Wang, Hong-Bo"
  17. AU="Zhong, Boyu"
  18. AU=Gimeno-Costa Ricardo AU=Gimeno-Costa Ricardo
  19. AU="Wu, Jiangbo"
  20. AU="MacIntyre, Michael F"
  21. AU="Moon, H K"
  22. AU="Clark, Mindie"
  23. AU="Nichols, Aaron L"
  24. AU="Cash-Goldwasser, Shama"
  25. AU="Christopher B. Daniels"
  26. AU="Wakama, Hitoshi"
  27. AU="Crowe, K"
  28. AU="Merz, Sabine"
  29. AU=Rossolatos George
  30. AU="Nalla, Shahed"
  31. AU="Alvarado, Miriam"
  32. AU="Garduño-Sánchez, Marco"
  33. AU="Khan, Sherbano"
  34. AU="Kakava, Felicia"

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: Steatosis regression assessed by cap after Vitamin 'D' supplementation in NAFLD patients with Vitamin 'D' deficiency.

Emam, Rabab Fouad / Soliman, Ahmed Fouad / Darweesh, Samar Kamal / AbdElmagid, Reham AbdElmoniem / Ibrahim, Ola Mohamed / Mohamed, Dina Mahmoud

European journal of gastroenterology & hepatology

2023  Band 36, Heft 1, Seite(n) 101–106

Abstract: Background: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, and previous studies suggested a relationship between vitamin D deficiency and NAFLD. It is suggested that vitamin D supplementation may have ... ...

Abstract Background: Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease, and previous studies suggested a relationship between vitamin D deficiency and NAFLD. It is suggested that vitamin D supplementation may have significant beneficial effect on liver biochemistry and histology.
Objective: This study aims to assess the degree of possible steatosis regression using controlled attenuation parameter (CAP) in NAFLD patients with vitamin D deficiency after vitamin D supplementation and evaluating its effect on lipid profile and transaminases.
Patients and methods: This study was conducted on 100 NAFLD patients with vitamin D deficiency. They received 10000 IU/week of vitamin D orally for 3 months. CAP was used to assess hepatic steatosis and fibrosis before/after intervention. Transaminases, lipid profile, and vitamin D levels were evaluated before/after treatment.
Results: Serum AST, ALT, cholesterol, TG, LDL and HDL showed a significant reduction posttreatment in patients with both normal and elevated baseline levels ( P < 0.001). The posttreatment mean CAP showed a significant reduction (300.44 ± 37.56 vs. 265 ± 36.19 dB/ml) ( P  < 0.001), and there was a significant improvement in the mean fibrosis values by LSM (5.32 ± 1.53 vs. 4.86 ± 1.28 KPa) ( P  = 0.001). After supplementation, serum vitamin D level was raised significantly in the majority of patients ( P  < 0.001); however, only 13% of them reached sufficient levels (>30 ng/ml), insufficient levels (20-29 ng/ml) was reached in 83% and 5% showed vitamin D deficiency (<20 ng/ml).
Conclusion: A significant improvement was detected in hepatic steatosis (by CAP); mean values of LSM, transaminases and lipid profile after three months of oral vitamin D supplementation.
Mesh-Begriff(e) Humans ; Non-alcoholic Fatty Liver Disease/complications ; Non-alcoholic Fatty Liver Disease/diagnostic imaging ; Non-alcoholic Fatty Liver Disease/drug therapy ; Vitamin D/therapeutic use ; Vitamin D Deficiency/complications ; Vitamin D Deficiency/diagnosis ; Vitamin D Deficiency/drug therapy ; Vitamins/therapeutic use ; Fibrosis ; Cholesterol ; Transaminases ; Dietary Supplements ; Elasticity Imaging Techniques
Chemische Substanzen Vitamin D (1406-16-2) ; Vitamins ; Cholesterol (97C5T2UQ7J) ; Transaminases (EC 2.6.1.-)
Sprache Englisch
Erscheinungsdatum 2023-11-09
Erscheinungsland England
Dokumenttyp Journal Article
ZDB-ID 1034239-4
ISSN 1473-5687 ; 0954-691X
ISSN (online) 1473-5687
ISSN 0954-691X
DOI 10.1097/MEG.0000000000002653
Signatur
Zs.A 2932: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang